A phase II study of carboplatin and chronic high-dose tamoxifen in patients with recurrent malignant glioma

By Tang P.   Roldan G.   Brasher P.M.A   Fulton D.   Roa W.   Murtha A.   Cairncross J.G.   Forsyth P.A.  

Journal of Neuro-Oncology, Vol. 78, Iss. 3, 2006-07 ,pp. : 311-316

Springer Publishing Company

Access to resources Recommend Favorite

Phase II Study of Bevacizumab and Vorinostat for Patients with Recurrent World Health Organization Grade 4 Malignant Glioma

By  

The Oncologist, Vol. 23, Iss. 2, 2018-02 ,pp. : 157-e21

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase II study of sunitinib malate in patients with recurrent high-grade glioma

By Neyns B.   Sadones J.   Chaskis C.   Dujardin M.   Everaert H.   Lv S.   Duerinck J.   Tynninen O.   Nupponen N.   Michotte A.   Greve J.  

Journal of Neuro-Oncology, Vol. 103, Iss. 3, 2011-07 ,pp. : 491-501

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study of combined chemotherapy with methotrexate, 5-fluorouracil, and low-dose cisplatin (MFP) for histologically diffuse-type advanced and recurrent gastric cancer (KDOG9501)

By Nakayama Norisuke   Koizumi Wasaburo   Tanabe Satoshi   Sasaki Tohru   Saigenji Katsunori  

Gastric Cancer, Vol. 9, Iss. 3, 2006-08 ,pp. : 185-191

Springer Publishing Company

Access to resources Recommend Favorite

Phase 1 clinical trial of bortezomib in adults with recurrent malignant glioma

By Phuphanich Surasak   Supko Jeffrey   Carson Kathryn   Grossman Stuart   Burt Nabors L.   Mikkelsen Tom   Lesser Glenn   Rosenfeld Steve   Desideri Serena   Olson Jeffrey  

Journal of Neuro-Oncology, Vol. 100, Iss. 1, 2010-10 ,pp. : 95-103

Springer Publishing Company

Access to resources Recommend Favorite